CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 74 filers reported holding CYTOSORBENTS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $420,000 | -29.3% | 135,134 | +0.8% | 0.00% | – |
| Q4 2021 | $594,000 | -54.0% | 133,997 | -9.3% | 0.00% | – |
| Q3 2021 | $1,290,000 | +12.4% | 147,786 | -2.8% | 0.00% | – |
| Q2 2021 | $1,148,000 | -18.2% | 152,065 | -5.9% | 0.00% | – |
| Q1 2021 | $1,403,000 | +9.5% | 161,602 | +0.6% | 0.00% | – |
| Q4 2020 | $1,281,000 | +7.8% | 160,681 | +7.9% | 0.00% | – |
| Q3 2020 | $1,188,000 | -15.1% | 148,897 | +5.4% | 0.00% | -100.0% |
| Q2 2020 | $1,399,000 | +49.9% | 141,290 | +17.1% | 0.00% | – |
| Q1 2020 | $933,000 | +119.5% | 120,709 | +9.3% | 0.00% | – |
| Q4 2019 | $425,000 | -23.4% | 110,398 | 0.0% | 0.00% | – |
| Q3 2019 | $555,000 | -27.9% | 110,398 | -5.3% | 0.00% | – |
| Q2 2019 | $770,000 | – | 116,547 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |